Ionis Pharmaceuticals | IONS - 股票



金融业
股票价格
USD
资产
USD 2.99B
现金及等价物
USD 350.07M
销售成本
USD 2.74M
流动资产
USD 2.49B
流动负债
USD 315.64M
债务
USD 1.91B
EBIT
USD -102.29M
EBITDA
USD -64.53M
员工
1.07K
EPS每股收益
USD -0.69
股本和储备
USD 439.74M
销售毛利
USD 265M
债务利息支出
USD 18M
利息收入
USD -0.66
贷款资金
USD 1.91B
市值
USD 6.56B
净收入
USD -114.65M
营业费用
USD 370.24M
营业利润
USD -102.29M
普通股股本
USD 165.64M
PE价格收益
396.15
税前利润
USD -114M
销售收入
USD 268M
销售和管理费用
USD 130.08M
股票
USD 50.83M
贸易债权人
USD 47.7M
应收帐款人
USD 58.85M


股票 更改 日
Agios Pharmaceuticals USD 35.75M 665K 2026-06
Alnylam Pharmaceuticals USD 97.11M 103.04M 2026-06
Arrowhead Research USD -173.08M 173.08M 2024-12
Astellas Pharma JPY 331.01B 33.75B 2026-03
BioCryst Pharmaceuticals USD 6.06M 71K 2026-06
BioMarin Pharmaceutical USD 1.78B 509.3M 2026-06
Celltrion KRW 126B 3.06B 2026-03
Cspc Pharmaceutical CNY 3.09B 219.95M 2025-12
Divis Laboratories Ltd INR 39.54B 7.18B 2026-03
Exelixis USD 28.73M 2.12M 2026-06
Halozyme Therapeutics USD 137.14M 18.33M 2026-06
Ionis Pharmaceuticals USD 50.83M 45.28M 2026-06
Kangmei Pharma CNY 2.38B 73.9M 2026-03
Knight Therapeutics CAD 95.4M 2.91M 2024-03
Laboratorios Farma EUR 327.67M 2.28M 2025-06
Medical Developments International AUD 9.45M 679K 2025-06
Moderna USD 280M 134M 2026-06
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 104.2M 39.7M 2026-06
Novartis USD 6.22B 66M 2026-06
Omeros USD 712K 266K 2021-09
OPKO Health USD 64.4M 1.4M 2026-03
Organigram Holdings CAD 135.16M 2.45M 2026-03
Pfizer USD 9.94B 722M 2026-06
Pharma Mar EUR 49.53M 3.59M 2026-06
PTC Therapeutics USD 91.35M 15.79M 2026-06
Qiagen NV USD 309.61M 7.72M 2026-03
Regeneron Pharmaceuticals USD 3.08B 19.3M 2026-06
Roche Holding CHF 7.6B 9M 2025-06
Sarepta Therapeutics USD 904.27M 96.84M 2026-06
Sartorius EUR 831.9M 4.8M 2026-06
Sino Biopharmaceutical CNY 1.84B 156.17M 2024-06
Tilray USD 282.79M 11.9M 2025-06
Ultragenyx Pharmaceutical USD 59M 4M 2026-06
Vertex Pharmaceuticals USD 1.77B 1.6M 2026-06
Zealand Pharma A/S 10.7M 9.9M 2024-12
Zz Pientze Pharmaceu CNY 6.28B 553.86M 2026-03